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Optical coherence tomography (OCT) is an optical analog of intravascular ultrasound (IVUS) that can be used to 
examine the coronary arteries and has 10-fold higher resolution than IVUS. Based on polarization properties, OCT can 
differentiate tissue characteristics (fibrous, calcified, or lipid-rich plaque) and identify thin-cap fibroatheroma. Because 
of the strong attenuation of light by blood, OCT systems required the removal of blood during OCT examinations. 
A recently developed frequency-domain OCT system has a faster frame rate and pullback speed, making the 
OCT procedure more user-friendly and not requiring proximal balloon occlusion. During percutaneous coronary 
intervention (PCI), OCT can provide detailed information (dissection, tissue prolapse, thrombi, and incomplete stent 
apposition [ISA]). At follow-up examinations after stent implantation, stent strut coverage and ISA can be assessed. 
Several OCT studies have demonstrated delayed neointimal coverage following drug-eluting stent (DES) implantation 
vs. bare metal stent (BMS) placement. While newer DESs promote more favorable vascular healing, the clinical 
implications remain unknown. Recent OCT studies have provided insights into restenotic tissue characteristics; DES 
restenotic morphologies differ from those with BMSs. OCT is a novel, promising imaging modality; with more in-depth 
assessments of its use, it may impact clinical outcomes in patients with symptomatic coronary artery disease.
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INTRODUCTION
Optical coherence tomography (OCT) is a method of 
obtaining tomographic images of a human organ based 
on the coherence of light. Around 1990, OCT was inde-
pendently developed by two Japanese researchers, Nao-
hiro Tanno of Yamagata University, Japan, and James G. 
Fujimoto of the Massachusetts Institute of Technology 
(MIT) in the United States, and patent applications were 
submitted at about the same time in Japan and the United 
States during 1991. In vitro observation of the retina and 
coronary artery was first performed in 1991 [1]. OCT was 
initially applied in the clinical setting in the ophthalmol-
ogy field in 1996 and is now widely used to assess retinal 
diseases and other conditions.
In cardiology, OCT is an optical analog of intravascular 
ultrasound (IVUS), used to examine the coronary arteries. 
Ultrasound employed for IVUS examination is replaced by 
near-infrared light with a wavelength of about 1,300 nm, 
which is absorbed by red blood cells, water, lipids, and 
protein at relatively low levels. Through a rotating glass 
fiber-optic system, coherent infrared light can be directed 2    The Korean Journal of Internal Medicine Vol. 27, No. 1, march 2012
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and reflected within the tissue to create a detailed tissue 
image with extraordinarily high resolution, and IVUS-like 
cross-sectional tomographic images can be obtained. OCT 
and IVUS differ in several respects, as shown in Table 1. 
The resolution of OCT (to 10-20 µm) is about 10-fold high-
er than that of IVUS (to 100-150 µm), but the maximum 
depth of tissue penetration is lower with OCT (1-2 mm) 
than with IVUS (4-8 mm). Another important difference 
is related to the strong attenuation of light by blood, which 
originates from two sources: absorption by hemoglobin 
and scattering by red blood cells. To examine coronary ar-
teries, blood must first be removed during an OCT exami-
nation to eliminate massive scattering of light by red blood 
cells.
OCT SYSTEM AND TECHNIQUE
Time-domain OCT
The first clinically/commercially available OCT system 
in the cardiology field was produced by LightLab Imag-
ing Inc. (Westford, MA, USA). The first-generation OCT 
(ImageWire and M2/3 OCT system; LightLab Imaging 
Inc.) incorporated both an OCT imaging wire and an over-
the-wire occlusion balloon. First, a conventional 0.014” 
angioplasty guide wire is used to cross the lesion and an 
occlusion balloon is passed along the guide wire beyond 
the lesion. Then, the guide wire and the imaging wire are 
exchanged. To examine the lesion, the occlusion balloon 
is pulled back proximal to the lesion and then dilated at a 
low pressure to block blood flow. Blood is then removed by 
flushing with lactated Ringer’s solution or normal saline. 
In our experience, symptoms and electrocardiographic 
changes often persist when normal saline is used for flush-
ing. Thus, we recommend the use of lactated Ringer’s 
solution. Advancing the occlusion balloon across a severe 
stenosis is occasionally difficult. In such cases, a skilled 
operator may cross an imaging wire alone across the se-
vere stenosis, and then dilate the occlusion balloon proxi-
mal to the lesion.
We conducted a multicenter study to evaluate the safety 
and efficacy of the first-generation OCT in comparison 
with IVUS, which revealed an average duration of vascular 
obstruction of 48.3 ± 14.7 seconds with no serious compli-
cation due to the procedure, including coronary artery dis-
section, embolism, severe arrhythmia (such as ventricular 
tachycardia or ventricular fibrillation), or myocardial 
infarction [2]. Additionally, OCT imaging was superior to 
IVUS for the visualization of the lumen border. Of note, 
the OCT image wire was able to cross five of six tight le-
sions that the IVUS catheter was unable to cross.
 Although the first-generation OCT had the disadvan-
tage of requiring a more complex procedure (i.e., balloon 
occlusion) than required with the IVUS, as described 
above, a more convenient method to remove blood was re-
cently introduced. Kataiwa et al. [3] and Prati et al. [4] re-
ported that blood could be removed by flushing with low-
molecular-weight dextran or contrast medium through a 
guide catheter instead of requiring an occlusion balloon 
for observation.
Frequency-domain OCT
The first-generation OCT system was based on a time-
domain OCT (TD-OCT) imaging method that relies on a 
moving reference mirror to scan each depth position in 
the image pixel. This mechanical scanning process lim-
its the rate at which images can be acquired (Fig. 1A). To 
overcome this limitation, a new generation of OCT systems 
that employ frequency-domain OCT imaging methods 
has been developed [5,6]. These systems are known as 
Table 1. Comparison of IVUS and first-generation time-domain OCT
Specifications IVUS First-generation OCT
Axial resolution, µm 100-150 10-20
Lateral resolution, µm 150-300 25-40
Frame rate, fps  30 15-20
Pullback speed, mm/sec 0.5-2.0 0.5-2.0
Scan diameter (FOV), mm 8-10 6.8
Tissue penetration, mm 4-8 1-2
Balloon occlusion Not necessary Highly recommended
IVUS, intravascular ultrasound; OCT, optical coherence tomography; fps, frames per second; FOV, field of view.Terashima m, et al. OCT role in PCI    3
http://dx.doi.org/10.3904/kjim.2012.27.1.1 http://www.kjim.or.kr
frequency-domain OCT (FD-OCT), Fourier-domain OCT, 
swept-source OCT (SS-OCT), or optical frequency-domain 
imaging (OFDI). In FD-OCT imaging methods, interfero-
metric data are measured as a function of optical wave-
length and time, rather than as a function of time alone, 
based on the introduction of a fixed reference mirror and 
a tunable laser light source with a sweep range of 1,250-
1,370 nm, instead of the broadband light source used in 
TD-OCT imaging systems (Fig. 1B). This imaging method 
enables much faster image acquisition rates and pullback 
speeds, resulting in a simpler, non-occlusive OCT imaging 
approach with flushing of viscous contrast through the 
guide catheter to remove blood from the artery [7].
Recently, a commercially available FD-OCT system 
has been developed (Dragonfly imaging catheter and C7-
XR OCT system; LightLab Imaging, Inc.). Differences 
between TD- (M3) and FD-OCT (C7-XR) systems are 
shown in Table 2. For FD-OCT imaging using the Drag-
onfly imaging catheter, a ≥ 6-Fr-diameter guide catheter 
is recommended. Viscous iso-osmolar contrast media or 
low-molecular-weight dextrose can be used for non-oc-
clusive flushing, although higher-viscosity solutions have 
been found to provide superior results. The OCT imaging 
catheter is advanced distally into the coronary artery via 
a standard angioplasty guide wire (0.014”). As with the 
non-occlusive TD-OCT technique, care should be taken to 
position the guide catheter coaxially and deeply into the 
coronary ostium. Automated intravascular OCT pullback 
is performed during contrast injection through the guide 
catheter, either automatically with a power injector (typical 
flush rate 3.0 mL/sec) or manually with a syringe.
A recent study showed that FD-OCT is a feasible and 
safe technique for the guidance of coronary interventions 
(see below) [3,7,8]. Larger randomized studies will con-
firm whether the use of FD-OCT can improve clinical out-
comes.
Figure 1. (A) Time-domain optical coherence tomography system. (B) Fourier/frequency-domain optical coherence tomography sys-
tem.
Table 2. Comparison of TD-OCT and FD-OCT
Specifications M3 (TD-OCT) C7-XR (FD-OCT)
Axial resolution, µm 15-20 12-15
Lateral resolution, µm 39 19
Frame rate, fps 20 100
Lines/frame 240 500
Pullback speed, mm/sec 0.5-2.0 10-25
Scan diameter (FOV), mm 6.8 10
Tissue penetration, mm 1-2 1-2
Balloon occlusion Highly recommended Optional
OCT, optical coherence tomography; TD, time-domain; FD, frequency-domain; fps, frames per second; FOV, field of view.
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EXAMINATION OF CORONARY ARTERY 
LESIONS AND OCT PLAQUE CHARAC-
TERISTICS
Due to its high resolution (10-15 µm), OCT can differen-
tiate the internal and external elastic laminae, as well as 
distinguish the intima/media/adventitia, which is impos-
sible with the low resolution (100-150 µm) of IVUS [9]. 
OCT can also differentiate tissue characteristics based on 
polarization properties. High birefringence by polarization 
shift identifies fibrous tissue, collagen, and lipid composi-
tion. Low birefringence reflects calcium. By overlying low 
and high birefringent images on the OCT image map, tis-
sue structures can be highlighted by tissue composition. In 
a comparison using autopsy specimens, Yabushita et al. [10] 
reported that OCT images of each type of plaque had the 
following features: 1) fibrous plaque: a homogenous high-
signal region with low attenuation; 2) calcified plaque: a 
well-delineated, low-signal region with sharp borders; 
and 3) lipid-rich plaque: a low-signal region with diffuse 
borders. They reported > 90% sensitivity and specificity 
for detecting lipid-rich plaque, based on comparisons with 
pathological specimens. In another study, Kume et al. [11] 
also concluded that OCT had a high sensitivity for detect-
ing lipid-rich plaque.
DIAGNOSIS OF UNSTAbLE PLAQUE
In addition to its ability to detect lipid-rich plaque, as 
mentioned above, the high resolution of OCT makes it pos-
sible to identify a very thin (< 100 µm) fibrous cap covering 
a lipid core, which is difficult to detect with other modali-
ties [12]. Autopsy studies demonstrated that fibroatheroma 
with a thin fibrous cap of < 65 µm (thin-cap fibroatheroma 
[TCFA]) is often found in culprit lesions in acute coronary 
syndromes (ACSs) and is considered to be a vulnerable 
plaque [13]. Early diagnosis of TCFAs may lead to more ag-
gressive medical/invasive treatment of symptomatic and 
asymptomatic coronary artery disease to improve progno-
sis and clinical outcomes.
OCT-derived TCFA was defined as a lipid-rich plaque 
(lipid arc within a plaque in ≥ 2 quadrants) with a thin 
fibrous cap (thickness at the thinnest segment < 65 µm) 
(Fig. 2) [14]. Our OCT examination of a patient with ACS 
revealed ruptured plaque with a thin fibrous cap at the site 
of a culprit lesion that could not be detected by IVUS (Fig. 
3). Kubo et al. [15] assessed culprit lesions in patients with 
acute myocardial infarction by OCT, IVUS, and coronary 
angioscopy, and reported that OCT was the most sensitive 
imaging modality for detecting the rupture and erosion 
of culprit plaque, and most frequently detected TCFAs. 
Additionally, OCT can distinguish between red and white 
thrombi using differences in the signal attenuation curve, 
which are frequently observed in unstable plaque [16].
Moreover, OCT may be able to assess inflammatory cell 
infiltration, primarily active macrophages, another char-
acteristic of unstable plaque. Based on OCT examination, 
MacNeill et al. [17] reported that plaque in patients with 
ACS had a high density of macrophages, and that this den-
sity was higher in ruptured plaque than in non-ruptured 
plaque.
While many authors have reported on the usefulness 
of OCT for tissue characterization, as indicated above, 
Manfrini et al. [18] performed a comparison with patho-
logical findings and found that the detection rates by OCT 
Figure 2. Optical coherence tomography-derived thin-cap fi-
broatheroma was defined as a lipid-rich plaque (lipid arc within a 
plaque in ≥ 2 quadrants) with a thin fibrous cap (thickness at the 
thinnest segment < 65 µm).
Lipid arc > 180°
Fibrous cap 
thickness
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differed for each type of plaque (45% for fibrous-cap ath-
eroma, 68% for fibrocalcific plaque, and 83% for fibrous 
plaque). They suggested that the low detection rates for 
fibrous-cap atheroma and fibrocalcific plaque may be due 
to the inability to detect the lipid core and calcium depos-
its located behind a thick fibrous cap because of the low 
tissue penetration of OCT, and that the lipid core and cal-
cium deposits were both seen as low-intensity areas that 
were difficult to distinguish. Low tissue penetration is a 
fundamental limitation of the current system. Moreover, 
distinguishing lipid from calcium is a subjective process 
and its precision could depend on the skill of the observer, 
as is the case for gray-scale IVUS. Thus, establishing ob-
jective diagnostic criteria is desirable.
APPLICATION OF OCT IN PERCUTANE-
OUS CORONARY INTERVENTION (PCI) 
 
Because OCT has a high resolution, it can provide 
detailed information about the vessel that cannot be ob-
tained with other modalities. Example cases are shown 
in Figs. 4 and 5. The case depicted in Fig. 4 demonstrated 
spontaneous dissection that could not be found on an-
giography or IVUS. Fig. 5 shows an example of a cutting 
balloon angioplasty. Multiple tears in the intima were 
observed after dilatation with a cutting balloon that also 
could not be detected by angiography or IVUS. Thus, this 
technology offers detailed visualization of vessel injury af-
ter stent implantation, such as tissue prolapse, dissections, 
and thrombus, and enables systematic classification and 
quantification in vivo [19,20].
After implantation of a drug-eluting stent (DES), not 
only dissection, tissue prolapse, and thrombi, but also in-
complete stent apposition (ISA), have attracted attention 
in relation to stent thrombosis and should be assessed in 
detail [19]. When assessing ISA, we should recall that the 
near-infrared light used in OCT does not penetrate metal 
stent struts, similar to IVUS. The stent strut is visual-
ized as a linear structure with strong surface reflection 
and typical dorsal shadowing, and the posterior side of 
each strut near the vessel wall cannot be observed (Fig. 
6) [21,22]. Thus, it is necessary to determine whether the 
strut has made an indentation on the intimal surface of 
the vessel (Fig. 6A) or to measure the distance between 
the surface reflection of the strut and the adjacent visible 
vessel surface while taking the thickness of the strut into 
account (Fig. 6B). To ensure the accurate assessment of 
ISA, we validated the accuracy of OCT measurement of the 
strut thickness of several commercially available stents 
in vitro. Differences in OCT stent strut measurements as 
compared with the manufacturers’ nominal strut thick-
Figure 3. Optical coherence tomography image of ruptured plaque (arrows) with a thin fibrous cap at the site of an acute coronary syn-
drome culprit lesion.6    The Korean Journal of Internal Medicine Vol. 27, No. 1, march 2012
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ness data were small and reproducibility of the measure-
ments was high, suggesting that the assessment of stent 
strut apposition using OCT is feasible [21].
As described above, the capability of OCT to examine 
the structure of the arterial wall before or after PCI is su-
perior to those of other imaging modalities, such as angi-
ography and IVUS, and the application of OCT during PCI 
seems logical and promising, yet the assessment of clinical 
significance to date has been limited to observations and 
has not necessarily included clinical outcomes. Further-
more, OCT has several inherent limitations. Given its lim-
ited penetration depth and/or scan range, the whole-vessel 
structure of a lesion with a large plaque burden or a large 
vessel cannot be visualized. Additionally, first-generation 
TD-OCT also requires displacement of the blood during 
imaging with balloon occlusion methods, making the PCI 
procedure more complex and precluding the use of this 
technique for ostial lesions, including the left main coro-
nary artery (lesions). As the newly developed FD-OCT 
system does not require coronary artery occlusion and has 
a faster pullback speed [5,6], it may be more suitable for 
PCI. The clinical significance of OCT for PCI needs to be 
further established in larger-scale clinical trials.
OCT FOLLOW-UP EXAMINATIONS AFTER 
PCI
Stent strut coverage and ISA
DESs significantly suppress neointimal hyperplasia. A 
study of OCT and IVUS demonstrated that two-thirds of 
sirolimus-eluting stent (SES) struts are covered by neointi-
Figure 4. A case with spontaneous dissection. Optical coherence tomography (C) visualized spontaneous dissection that could not be 
found with angiography (A) or intravascular ultrasound (B).
b
C
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Figure 5. A case with cutting balloon angioplasty. Cutting balloon angioplasty was performed for stenosis in the right posterior de-
scending artery (A, arrow). Multiple tears in the intima were observed after dilatation with a cutting balloon on the optical coherence 
tomographic image (D), which could not be detected by angiography (B, arrow) or intravascular ultrasound (C).
D C
Figure 6. Identification of stent apposition. The stent is visualized as a linear structure with strong surface reflection and typical dorsal 
shadowing, and the posterior side of each strut near the vessel wall cannot be observed. Thus, it is necessary to determine whether the 
strut has made an indentation on the intimal surface of the vessel (A) or to measure the distance between the surface reflection of the 
strut and the adjacent visible vessel surface while taking the thickness of the strut into account (B).
Complete stent apposition
Incomplete stent apposition
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≤ Thickness
   of strut
> Thickness
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ma < 100 µm in thickness, which is beyond the resolution 
of IVUS [23]. Thus, OCT is most useful for examining pa-
tients at follow-up after DES implantation, and is capable 
of detecting a thin neointima due to its high resolution (Fig. 
7). In recent years, late stent thrombosis in patients treated 
with DES has become a major concern. Delayed cover-
age or failure to cover an exposed stent with neointima/
regenerated endothelium has been suggested as a cause of 
thrombosis.
Both OCT and angioscopy have been recognized as use-
ful methods for in vivo assessment of the intimal coverage 
of a stent. Although angioscopy provides a wide-angle 
forward view, anatomical structures, such as tortuous ves-
sels, may prohibit a complete circumferential view. While 
angioscopy allows direct observation of the vascular lu-
men and endothelial surface, the internal structure of the 
vessel wall cannot be assessed. Given these disadvantages 
of angioscopy, OCT may offer better quantitative perfor-
mance for assessments. Thus, longitudinal/serial OCT 
studies (pre/post-intervention vs. follow-up) have been 
performed to evaluate the tissue coverage response of the 
artery to stent implantation [23-26].
Several classifications of tissue coverage of a stent strut 
are available [24,27]. In 2006, we proposed the OCT 
classification of tissue coverage of struts shown in Fig. 8 
[28,29]. Although consensus on the definitions of the tis-
sue coverage of stent struts has not yet been obtained, our 
classification is similar to that of Guagliumi and Sirbu 
[27]. The stent struts were usually assessed at 1-mm in-
tervals, and strut, cross-section/frame, and stent/patient-
base analyses were performed. Observations of struts in 
the same stent are not independent of one another. Using 
OCT, many papers demonstrated a delay in neointimal 
coverage following DES implantation in comparison with 
that of bare metal stents (BMSs), corresponding to patho-
logical data. In comparisons among different kinds of 
DESs, second-generation DESs (zotarolimus-eluting [En-
deavor, Medtronic CardioVascular, Santa Rosa, CA, USA] 
or everolimus-eluting [Xience V, Abbott Vascular Devices, 
Abbott Park, IL, USA; Promus, Boston Scientific, Natick, 
MA, USA]) demonstrated more favorable vascular healing 
following stent implantation, better neointimal coverage, 
and less ISA than did first-generation DESs (sirolimus-
eluting [Cypher, Cordis Johnson & Johnson, Hialeah, FL, 
USA] or paclitaxel-eluting [TAXUS, Boston Scientific] 
stents) [25,30-32]. Furthermore, the healing processes are 
delayed in patients with ACS (especially ST-segment-ele-
vation myocardial infarction) in comparison with patients 
with stable angina pectoris [33-35]. Stent overlapping or 
bifurcation/branching also affects stent strut coverage 
[36-39].
Thus, it is expected that detailed findings obtained by 
Figure 7. Intravascular ultrasonic (IVUS) and optical coherence tomographic (OCT) images obtained at 7 months after implantation 
of a drug-eluting stent (Cypher; 3.0 × 18 mm). While no obvious intimal growth is observed on the IVUS image (A), the OCT image (B) 
shows that the stent strut is covered by a very thin neointima (-100 µm).
A bTerashima m, et al. OCT role in PCI    9
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OCT will be able to determine the characteristics of the 
neointima after various types of DES implantation, factors 
contributing to restenosis or thrombosis of DESs, and the 
proper use and appropriate duration of antiplatelet thera-
py after DES placement.
Restenotic tissue characteristics
OCT provides new insights into the characteristics of 
the tissue covering the stent struts. Several papers have 
reported OCT patterns of restenotic tissue components. 
A typical restenotic tissue of BMS at early follow-up (to 
1 year), recognized as neointimal hyperplasia primarily 
composed of smooth muscle cells, is visualized as a homo-
Figure 8. Classification of tissue coverage of stent struts. The left images (A, B) show uncovered struts and the right images (C, D) show 
covered struts. A strut with surrounding tissue beyond the strut surface is defined as covered. According to the shape of the tissue cover-
ing the struts, a covered strut is classified as convex (C) or embedded (D). The intimal thickness (NIT) was measured from the surface of 
the neointima covering the strut to the center line of the reflection.
Figure 9. Optical coherence tomographic patterns of restenotic tissue following bare metal stent implantation. Homogeneous (A) and 
heterogeneous (B, C) intima. Lipid accumulation is suggested in the low-signal area with a diffuse lumen border within the area of neo-
intimal hyperplasia (* in B), and calcification in the low-signal area with a sharp lumen border (* in C).
A b C
A C
b D
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geneous structure by OCT (Fig. 9A) [40]. We have, howev-
er, reported that the characteristics of restenotic tissue in 
the very late phase (> 5 years) is frequently demonstrated 
as a heterogeneous structure suggesting lipid accumula-
tion/calcification (Fig. 9B and 9C), occasionally accom-
panied by disruption of the intima, microvessels within 
neointima, or intraluminal materials [41]. The restenotic 
tissue of DESs, even in an early phase, also demonstrates 
polymorphic patterns in structure, backscatter, and com-
position (Fig. 10) [42,43]. This variation in OCT images 
could be caused by diverse components, including mature/
immature smooth muscle cells and persistent fibrin or ex-
tracellular matrix, such as proteoglycans [43]. Thus, OCT 
provides important information about the tissue cover-
ing the stent struts. However, few studies have sought to 
validate OCT findings in comparison with pathological 
findings, and further investigations should be conducted 
until the impact of these findings on clinical outcomes is 
known.
FUTURE DIRECTIONS
As described above, OCT is a novel, promising imag-
ing modality with characteristics that differ from those 
of traditional modalities, such as IVUS and angioscopy. 
However, OCT does not yet have the established clinical 
profile or ease-of-use of IVUS. As described, the advent 
of next-generation OCT, FD-OCT, is expected to make the 
procedure easier and faster. Since OCT has received more 
attention in Korea, Japan, China, and Europe, increas-
ing numbers of OCT studies are being reported. Through 
these studies, we hope that the clinical role of OCT in PCI 
will be clarified in the future. We believe that the clinical 
usefulness of FD-OCT is likely to be greater than that of 
standard/previous-generation TD-OCT.
CONCLUSIONS
OCT is an imaging modality that can be expected to be-
come increasingly popular in the future for the diagnosis 
and treatment of patients with symptomatic/asymptom-
atic coronary artery disease.
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